216 related articles for article (PubMed ID: 2496657)
1. Inhibition of Pseudomonas aeruginosa exoenzyme expression by subinhibitory antibiotic concentrations.
Grimwood K; To M; Rabin HR; Woods DE
Antimicrob Agents Chemother; 1989 Jan; 33(1):41-7. PubMed ID: 2496657
[TBL] [Abstract][Full Text] [Related]
2. Subinhibitory antibiotics reduce Pseudomonas aeruginosa tissue injury in the rat lung model.
Grimwood K; To M; Rabin HR; Woods DE
J Antimicrob Chemother; 1989 Dec; 24(6):937-45. PubMed ID: 2516085
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa.
Mizukane R; Hirakata Y; Kaku M; Ishii Y; Furuya N; Ishida K; Koga H; Kohno S; Yamaguchi K
Antimicrob Agents Chemother; 1994 Mar; 38(3):528-33. PubMed ID: 8203850
[TBL] [Abstract][Full Text] [Related]
4. Postantibiotic effects of subinhibitory concentrations of some antibiotics and their influence on Pseudomonas aeruginosa enzymic activity.
Hostacká A
Folia Microbiol (Praha); 1996; 41(1):39-42. PubMed ID: 9090822
[TBL] [Abstract][Full Text] [Related]
5. Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis.
Grimwood K; Semple RA; Rabin HR; Sokol PA; Woods DE
Pediatr Pulmonol; 1993 Mar; 15(3):135-9. PubMed ID: 8327274
[TBL] [Abstract][Full Text] [Related]
6. Sub-inhibitory concentrations of ceftazidime and tobramycin reduce the quorum sensing signals of Pseudomonas aeruginosa.
Garske LA; Beatson SA; Leech AJ; Walsh SL; Bell SC
Pathology; 2004 Dec; 36(6):571-5. PubMed ID: 15841693
[TBL] [Abstract][Full Text] [Related]
7. Construction and characterization of chromosomal insertional mutations of the Pseudomonas aeruginosa exoenzyme S trans-regulatory locus.
Frank DW; Nair G; Schweizer HP
Infect Immun; 1994 Feb; 62(2):554-63. PubMed ID: 8300213
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin resistance and tolerance of Pseudomonas aeruginosa ocular isolates.
Khan M; Ma K; Wan I; Willcox MD
Cont Lens Anterior Eye; 2023 Jun; 46(3):101819. PubMed ID: 36732125
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites.
Woods DE; Schaffer MS; Rabin HR; Campbell GD; Sokol PA
J Clin Microbiol; 1986 Aug; 24(2):260-4. PubMed ID: 3018037
[TBL] [Abstract][Full Text] [Related]
10. Production of extracellular virulence factors by Pseudomonas aeruginosa isolates obtained from tracheal, urinary tract, and wound infections.
Hamood AN; Griswold JA; Duhan CM
J Surg Res; 1996 Mar; 61(2):425-32. PubMed ID: 8656619
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of
Mataraci Kara E; Yilmaz M; İstanbullu Tosun A; Özbek Çelik B
Infect Dis (Lond); 2020 Sep; 52(9):616-624. PubMed ID: 32427010
[No Abstract] [Full Text] [Related]
12. Use of transposon mutants to assess the role of exoenzyme S in chronic pulmonary disease due to Pseudomonas aeruginosa.
Woods DE; Sokol PA
Eur J Clin Microbiol; 1985 Apr; 4(2):163-9. PubMed ID: 2988944
[TBL] [Abstract][Full Text] [Related]
13. Role of exoenzyme S in chronic Pseudomonas aeruginosa lung infections.
Nicas TI; Frank DW; Stenzel P; Lile JD; Iglewski BH
Eur J Clin Microbiol; 1985 Apr; 4(2):175-9. PubMed ID: 2988945
[TBL] [Abstract][Full Text] [Related]
14. Contribution of exoenzyme S to the virulence of Pseudomonas aeruginosa.
Nicas TI; Iglewski BH
Antibiot Chemother (1971); 1985; 36():40-8. PubMed ID: 2988426
[TBL] [Abstract][Full Text] [Related]
15. Development of antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseudomonal treatment at the Danish CF Center.
Ciofu O; Giwercman B; Pedersen SS; Høiby N
APMIS; 1994 Sep; 102(9):674-80. PubMed ID: 7946270
[TBL] [Abstract][Full Text] [Related]
16. Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
Kumar A; Hay MB; Maier GA; Dyke JW
J Antimicrob Chemother; 1992 Nov; 30(5):597-602. PubMed ID: 1283606
[TBL] [Abstract][Full Text] [Related]
17. Production of exoenzyme S by clinical isolates of Pseudomonas aeruginosa.
Sokol PA; Iglewski BH; Hager TA; Sadoff JC; Cross AS; McManus A; Farber BF; Iglewski WJ
Infect Immun; 1981 Oct; 34(1):147-53. PubMed ID: 6271678
[TBL] [Abstract][Full Text] [Related]
18. Postantibiotic effect and virulence factors depression induced by ciprofloxacin and by aminoglycosides in a clinical isolate of Pseudomonas aeruginosa.
Hostacka A
Zentralbl Bakteriol; 1996 Mar; 283(3):322-7. PubMed ID: 8861870
[TBL] [Abstract][Full Text] [Related]
19. The frequency of genes encoding exotoxin A and exoenzyme S in Pseudomonas aeruginosa strains isolated from burn patients.
Khosravi AD; Shafie F; Abbasi Montazeri E; Rostami S
Burns; 2016 Aug; 42(5):1116-1120. PubMed ID: 27263417
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection.
Blackwood LL; Stone RM; Iglewski BH; Pennington JE
Infect Immun; 1983 Jan; 39(1):198-201. PubMed ID: 6401692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
